Project Description
Dr Gustavo Bracho, an immunologist with the Carlos J. Finlay Institute, a world renowned center for vaccine research and production in Havana, Cuba used HP for 2.3 million people in 2007 and 2008. Dr. Bracho is Advisor to the President and General Director of Finlay Institute, and head of the Homeopathy and Biotherapic Projects at the Institute. He is an experienced researcher in molecular and cellular biology, and has headed the Adjuvant Group within the Immunology Department of Finlay.
The PubMed study states: